Remarkably, reducing Mrps5 and deleting Cpt1b not only led to hyperplastic hearts, but these mutations also promoted cardiac regeneration after myocardial infarction (MI) and ischemic-reperfusion injury, respectively (Gao et al. 2023; Li et al. 2023). The gene discussed is CPT1B; the disease is myocardial infarction.